Armistice Capital’s ENvue Medical Inc FEED Stock Holding History

Armistice Capital’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-143	Closed	-$112K	–	270
2024 Q4	$112K	Sell	143 -68	-32%	-$55K	﹤0.01%	202
2024 Q3	$171K	Buy	211 +107	+103%	+$93.4K	﹤0.01%	224
2024 Q2	$95.8K	Sell	104 -86	-45%	-$87.9K	﹤0.01%	227
2024 Q1	$226K	Buy	+190	New	+$247K	﹤0.01%	261
2023 Q4	–	Sell	-22	Closed	-$57.2K	–	340
2023 Q3	$57.2K	Buy	+22	New	+$78.6K	﹤0.01%	225

Other funds holding FEED

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Armistice Capital's FEED Position: Q1 2025 in Review

Armistice Capital sold out of ENvue Medical Inc (FEED) in Q1 2025, closing a stake of 143 shares — an estimated $112K sold.

Armistice Capital first reported a position in FEED in Q3 2023 and held it in 5 quarters. The position peaked at $226K in Q1 2024. 3 funds tracked by Wall St. Rank hold FEED as of Q1 2025.

Armistice Capital reported no remaining ENvue Medical Inc position as of Q1 2025 after selling out during the quarter.
Armistice Capital sold 143 ENvue Medical Inc shares in Q1 2025, an estimated $112K.
Armistice Capital first reported a position in ENvue Medical Inc in Q3 2023 and held it in 5 quarters.
Armistice Capital's ENvue Medical Inc position peaked at $226K in Q1 2024.
3 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.